Rutin

NEWENTRY ; Severe acute respiratory syndrome-related coronavirus







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35233172 Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies. 2022 May 1
2 35364308 Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19. 2022 Jun 1
3 35431327 Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies. 2022 Sep 5 2
4 33798836 Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. 2021 Jun 1
5 34649146 Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study. 2021 Dec 2
6 34690453 Computational screening of natural compounds from Salvia plebeia R. Br. for inhibition of SARS-CoV-2 main protease. 2021 Oct 19 2
7 33140777 Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease. 2020 Nov 21 4
8 33542917 In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19. 2020 1